1Sacco RL,Adams R,Albers G,et al.Guidelines for prevention of strokein patients with ischemic stroke or transient ischemic attack:a statementfor healthcare professionals from the American Heart Association/Ameri-can Stroke Association Council on Stroke:co-sponsored by the Council onCardiovascular Radiology and Intervention:the American Academy ofNeurology affirms the value of this guideline〔J〕.Circulation,2006;113:e409-49.
7Vernieri F,Pasqualetti P,Matteis M,et al.Effect of collateral blood flowand cerebral vasomotor reactivity on the outcome of carotid artery occlu-sion〔J〕.Stroke,2001;32(7):1552-8.
8Claassen JA,Zhang R,Fu Q,et al.Transcranial Doppler estimation ofcerebral blood flow and cerebrovascular conductance during modified re-breathing〔J〕.J Appl Physiol,2007;102(3):870-7.
2Ishibashi M, Egashira K, Hiasa K, et al. Antiinflammatory and antiarteriosclerotic effects of pioglitazone. Hypertension, 2002, 40:687-693.
3Pasceri V, Wu HD, Willerson JT, et al. Modulation of vascular inflammation in vivo and in vitro by peroxisome proliferators-activator-γ activators. Circulation, 2000,101:235-238.
4Libby P. Current concepts of the pathogenesis of the acute coronary syndrome. Circulation, 2001, 104: 365-372.
5Jovinge S, Ares MP, Kallin J, et al. Human monocytes/macrophages release TNF-alpha in responsible to OxLDL. Atherioscler Thromb Vasc Biol, 1996, 16: 1573-1579.
6The Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 1994,344:1383-1389.
7Inoue S, Egashira K, Ni W, et al. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atheroslerosis in apolipoprotein E-Knockout mice. Circulation, 2002, 106: 2700-2706.
8Brown DL, Hibbs MS, Kearney M,et al. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation, 1995, 91:2125-2131.
9Galis ZS, Johnson C, Godin D, et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res, 2002, 91:852-859.
8Tang XL, Sanganalmath SK, Sato H, et al. Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and re- modeling after myocardial infarction [J] . PLoS One, 2011, 6 (9) : e25320.
9Keyamura Y, Nagano C, Kohashi M, et al. Add-on effect of probucol in atheroselerotic, cholesterol-fed rabbits treated with atorvastatin [J] . PLoS One, 2014, 9 (5) : e96929.
10Nie P, Li D, Hu L, et al. Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine recep- tors [J] . PLoS One, 2014, 9 (5) : e97009.
